This bill builds a permanent statutory framework for reproductive-assistance services across the Department of Defense and Department of Veterans Affairs. It directs DoD to offer fertility treatment, preservation, and counseling to active-duty service members and their spouses/partners/gestational surrogates, and it adds a new VA benefit for enrolled veterans along with limited adoption aid and research facilitation.
Why it matters: the measure moves temporary or piecemeal authorities into statutory law, creates explicit rules on storage and consent, directs agency coordination and rulemaking, and will affect military health operations, VA benefit design, and departmental budgets and administration.
At a Glance
What It Does
The bill requires DoD to offer fertility treatment and counseling and to establish protocols for retrieval, cryopreservation, shipping, and storage of reproductive genetic material for at-risk active-duty members. It adds fertility treatment and counseling to VA medical services (new 38 U.S.C. §1720M), authorizes adoption assistance (new §1790), and charges both agencies to coordinate, research, and issue implementing regulations within two years.
Who It Affects
Directly affects active-duty service members (and their spouses, partners, gamete donors, and gestational surrogates), enrolled veterans, military and VA medical personnel, and private clinics that provide cryopreservation and assisted-reproduction services. It also implicates administrators who must implement memoranda of understanding and new enrollment and consent processes.
Why It Matters
This standardizes family‑building supports previously handled by temporary appropriations and agency policy, sets precise benefit limits and cost-shifting rules, and creates new operational duties (storage logistics, consent documentation, cross‑agency referrals) that will have budgetary and legal consequences for DoD, VA, and private providers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates two parallel but coordinated tracks: Title I for active-duty service members through DoD, and Title II for veterans through VA. For DoD, the Assistant Secretary for Health Affairs must write procedures to retrieve reproductive genetic material as soon as medically appropriate after injury or illness that threatens fertility, and to include questions about fertility-preservation consent and post‑death or incapacity use in standard advance medical directives and military testamentary instruments.
DoD must offer retrieval, testing, cryopreservation, shipping, and storage to members prior to combat deployments or hazardous assignments (the statute expressly names PFAS exposure as an example). DoD pays these costs at no charge while the member is on active duty and continues storage at no cost until one year after retirement, separation, or release; after that year the individual may either continue storage at their own expense or transfer material to a private facility.
The law allows members to elect the use of donor material and requires DoD to pay or reimburse reasonable procurement costs for donor gametes when a member cannot provide their own.The VA side adds fertility treatment and counseling to the statutory definition of medical services and creates 38 U.S.C. §1720M to authorize care for enrolled (“covered”) veterans and their spouse/partner/gamete donor/gestational surrogate, subject to informed consent rules the Secretary will prescribe. The VA may require a veteran to pay applicable copayments for fertility treatment when those copayments otherwise apply.
The law also creates an adoption-assistance authority that the Secretary may use up to a limit defined as the Department’s cost to pay for up to three adoptions by covered veterans.Crosscutting provisions require DoD and VA to share best practices, facilitate referrals, and enter an MOU to coordinate fertility-preservation care and to let VA compensate DoD for cryopreservation, transport, and storage where veterans transition. Both Secretaries must issue implementing regulations within two years.
The bill also directs VA to facilitate collaborative research with HHS and DoD on reproductive health needs of veterans and to disseminate findings across VHA.
The Five Things You Need to Know
The bill caps in‑vitro fertilization cycles to not more than three completed oocyte retrievals per individual but allows unlimited embryo transfers.
DoD must offer retrieval, cryopreservation, shipping, testing, and storage of reproductive material before deployment to combat zones or hazardous assignments (explicitly including PFAS exposure) and pay those costs while a member is on active duty.
DoD-funded storage continues at no cost only until one year after a member’s retirement, separation, or release; after that the service member must pay storage costs or transfer material to a private facility.
VA’s new benefit (38 U.S.C. §1720M) furnishes fertility treatment and counseling to enrolled veterans and their spouses/partners/gestational surrogates, but veterans must pay any applicable VA copayments for those services.
Section 1790 authorizes adoption assistance for covered veterans with a statutory cap defined as the Department’s cost equivalent to paying expenses for up to three adoptions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
DoD fertility treatment and inclusive eligibility
This section directs the Secretary of Defense to make fertility treatment and counseling available to members and their spouse/partner/gestational surrogate and expressly bars discrimination on sex, sex characteristics, gender identity, sexual orientation, infertility diagnosis, or marital status. It defines fertility services broadly (preservation, artificial insemination, ART including IVF, genetic embryo testing, medications, gamete donation, and other clinically appropriate services). Practically, DoD must expand covered services beyond emergency trauma care to family‑building care and create clinical pathways and referral relationships with private providers where necessary.
Post‑injury fertility‑preservation procedures and consent documentation
This provision requires DoD to establish procedures to retrieve reproductive material promptly when an injury or illness threatens fertility, and it requires fertility‑preservation consent and disposition preferences to be captured in advance medical directives and military testamentary instruments. Implementation will require new clinical protocols, training for trauma teams, and standardized legal forms to record ownership and use preferences at the point of care.
Cryopreservation before deployment and storage timeline
DoD must offer retrieval, testing, cryopreservation, shipping, and storage prior to deployment to combat zones and hazardous assignments (the statute lists PFAS exposure explicitly and leaves room for Secretary‑determined categories). DoD pays these services until one year after separation, at which point service members choose to pay for continued storage or transfer material. This shifts substantial logistics and contracting work to Military Treatment Facilities and private labs and creates a discrete post‑service cost point for individuals.
Navigation, continuity, coordination, and rulemaking
DoD must provide personnel to help service members navigate these benefits, find providers, and prevent interruptions during permanent changes of station. Sections 106–107 require DoD and VA to share best practices and enter an MOU to coordinate care and payment for cryopreservation when members become veterans, and require DoD to issue regulations within two years. That timeline concentrates policy design and contracting decisions into a fixed regulatory window.
VA statutory benefit design and limits
Title II inserts fertility treatment and counseling into the statutory definition of medical services and creates §1720M, which requires VA to furnish fertility treatment and counseling to covered veterans and specified family members with informed consent processes. The statute mirrors DoD’s inclusive eligibility language, permits donor‑material procurement and reimbursement, and places a copayment rule: if a veteran is subject to routine VA copayments, the veteran must agree to pay the applicable copayment for fertility services.
Adoption assistance authority
This new section authorizes the Secretary to pay adoption‑related costs for covered veterans up to a statutory limitation pegged to the Department’s cost of covering up to three adoptions. The provision is nondiscriminatory by sex, gender identity, sexual orientation, and marital status and gives VA discretionary authority to design an assistance program within that cap.
Research facilitation and regulatory closure of temporary authorities
VA must facilitate collaborative reproduction and infertility research with DoD and HHS and ensure useful findings are shared across VHA. The bill also provides two‑year deadlines for VA to issue implementing regulations for the new benefit and for the DoD rulemaking, and it sunsets prior temporary authorities (e.g., the 2024 Military Construction/VA appropriations authority) once VA promulgates its regulations.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Active-duty service members at risk of fertility loss — they receive prompt preservation procedures, no‑cost retrieval and storage during service, and a statutory mechanism to protect their post‑injury reproductive options.
- Enrolled veterans and their spouses/partners/gestational surrogates — VA will cover fertility treatment and counseling under §1720M and may reimburse donor procurement and related travel costs, expanding covered family‑building pathways for veterans.
- Service members and veterans who need donor gametes or gestational surrogacy — the statute authorizes procurement and reimbursement for donor material and allows use of donated gametes where a member/veteran cannot provide their own.
- Family‑building and reproductive medicine providers — private clinics and cryobanks gain a clearer payer (DoD/VA) for indexed services, plus an MOU framework for transfers and compensation when members transition to veteran status.
- Researchers and VHA clinicians — a mandated interagency research facilitation and dissemination duty should increase data and protocols on the long‑term reproductive health of veterans, informing clinical practice.
Who Bears the Cost
- Department of Defense — must fund retrievals, cryopreservation, shipping, storage while members are on active duty, establish new clinical and administrative processes, and stand up navigation services and training programs.
- Department of Veterans Affairs — will absorb costs for fertility services provided to enrolled veterans (subject to copayments) and must develop enrollment, consent, outreach, provider networks, and regulations within a two‑year window.
- Individual veterans after separation — the law forces a post‑service cost choice: pay ongoing storage fees or transfer material at personal expense after one year, shifting long‑term costs to individuals.
- Private cryopreservation facilities and clinics — while they may get new business and contracts, they will carry operational burdens (chain‑of‑custody, transfers, varying payer rules) and may need to renegotiate rates to reflect government reimbursement.
- Taxpayers/general appropriations — the new statutory entitlements and required interagency coordination create new budgetary pressures on DoD and VA appropriations, including potential costs for donor procurement and travel reimbursements.
Key Issues
The Core Tension
The bill balances two strong but competing goals: expand reliable, nondiscriminatory family‑building options for service members and veterans, while containing government exposure and preserving administrative feasibility. Achieving both requires detailed regulatory choices and interagency bargains that will determine whether the statute operates as robust entitlement or a narrowly administered benefit with significant out‑of‑pocket costs for individuals.
Two implementation bottlenecks will determine how expansive these benefits become: the two‑year regulatory deadlines and the terms of the DoD–VA memorandum of understanding. The statute creates entitlements in broad strokes but leaves key operational matters to regulations and MOUs — provider networks, prior authorization processes, price reasonableness standards for donor procurement, and details on how VA will reimburse DoD for stored material are all delegated.
Those choices will affect access, cost, and legal risk.
The bill also creates unresolved legal and administrative tensions around ownership, consent, and cross‑jurisdictional conflicts. It requires members to record disposition preferences in advance directives and testamentary instruments, but it leaves disputes over ownership and future disposition squarely with the private parties and facilities storing material.
At the same time, §1720M begins with a sweeping “notwithstanding any other provision of law, including the surrogacy laws of any State” clause requiring VA to furnish services regardless of state surrogacy laws; that language could provoke preemption challenges or practical conflicts when state law restricts aspects of surrogacy or gamete use. Finally, the one‑year post‑service free storage window is a blunt cost‑control lever: it facilitates immediate preservation but forces individuals to shoulder ongoing storage costs long‑term or risk transfer, potentially producing equity problems for lower‑income veterans or those with limited access to private cryobanks.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.